Qualitative protein nutrition in pregnant women is a prerequisite for the development of a healthy fetus and offspring after birth. Proteins, especially ideally balanced by the amino acid composition, are involved in anabolic processes, prevent premature births (premature birth) and discharges caused by physiological pathologies.
Particularly important is the entry of the valuable protein into the mother’s body during the period of mass distribution and differentiation of cerebral cortex neurons in the fetus, which occurs between 5 and 6 months of gestation. During this period in the brain of the fetus, there are processes that have consequences for all the further life of the child and then an adult.
In addition to direct positive effects on the body and the future human psyche, the drug “OMARIDIN™” enriches the body with the raw material for the synthesis of own proteins, which are involved in transferring to the goals of differentiation factors, which is the development of tight memory, creative abilities and synthetic-analytical properties of the brain And the formation of a healthy body of the fetus and the child.
Equated to the therapeutic dose for adults, that is, at the level of 1.75-2.0 g / kg body weight of the pregnant woman per day.
The use of the drug in pregnant women, with its maximum digestibility, is most effective in the interval between 12 and 18 hours, during the period of the greatest activity of enterocytes.
The product does not have a specific (estrogenic or androgenic) activity, therefore, it does not have a negative effect on the function of reproduction on the part of changes in the hormonal background.